OraSure Technologies | OSUR - Operating Expenses


OraSure Technologies reported $40.35M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.44B 27M Dec/2025
AngioDynamics USD 81.95M 1.68M Sep/2025
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Bio Techne USD 235.92M 5.5M Mar/2026
Bio-Rad Laboratories USD 6.85B 6.21B Mar/2026
Bruker USD 813.2M 87.7M Mar/2026
Cerus USD 34.78M 2.98M Dec/2024
Charles River Laboratories USD 875.93M 42.48M Mar/2026
Danaher USD 52.95B 47.61B Mar/2026
Dentsply International USD 1.32B 895M Mar/2026
Dexcom USD 936.6M 0 Mar/2026
Illumina USD 852M 51M Mar/2026
Integra LifeSciences USD 1.04B 673.49M Mar/2026
Intuitive Surgical USD 1.91B 89.8M Mar/2026
IQVIA Holdings USD 6.22B 4.53B Mar/2026
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Mettler Toledo International USD 713.2M 64.61M Mar/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quidel USD 1.85B 1.09B Mar/2026
Repligen USD 174.27M 3.67M Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
STAAR Surgical USD 76.12M 7.38M Mar/2026
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Trinity Biotech USD 14.82M 7.81M Sep/2025
Waters USD 1.12B 457.15M Mar/2026